Peter Atadja

Peter Atadja

Chief Tech/Sci/R&D Officer en CommBio Therapeutics Co., Ltd. .

64 años
Health Technology
Consumer Services

Perfil

Peter Atadja is currently the Chief Scientific Officer at CommBio Therapeutics Co., Ltd.
He previously worked at Novartis Pharmaceuticals Corp.
as the Executive Director & Head-Drug Discovery from 1997 to 2021.
Additionally, he served as an Independent Director at Traws Pharma, Inc. from 2022 to 2024.
Dr. Atadja also held the position of Chief Scientific Officer at K36 Therapeutics, Inc. in the past.
He holds a doctorate degree from the University of Calgary, a graduate degree from The Hebrew University of Jerusalem, and an undergraduate degree from Kwame Nkrumah University of Science & Technology.

Cargos activos de Peter Atadja

EmpresasCargoInicio
CommBio Therapeutics Co., Ltd. Chief Tech/Sci/R&D Officer -
Todos los cargos activos de Peter Atadja

Antiguos cargos conocidos de Peter Atadja.

EmpresasCargoFin
TRAWS PHARMA, INC. Director/Board Member 01/04/2024
Director/Board Member 01/01/2021
Chief Tech/Sci/R&D Officer -
Ver el detalle de la experiencia de Peter Atadja.

Formación de Peter Atadja.

University of Calgary Doctorate Degree
The Hebrew University of Jerusalem Graduate Degree
Kwame Nkrumah University of Science & Technology Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Peter Atadja.

Relaciones

100 +

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
TRAWS PHARMA, INC.

Health Technology

Empresas privadas3

Health Technology

CommBio Therapeutics Co., Ltd.

Health Technology

Ver las conexiones de la empresa